561 related articles for article (PubMed ID: 30282643)
21. Mutational profiling of myeloid neoplasms associated genes may aid the diagnosis of acute myeloid leukemia with myelodysplasia-related changes.
Yu J; Du Y; Jalil A; Ahmed Z; Mori S; Patel R; Varela JC; Chang CC
Leuk Res; 2021 Nov; 110():106701. PubMed ID: 34481124
[TBL] [Abstract][Full Text] [Related]
22. Acute Myeloid Leukemia With Myelodysplasia-Related Changes.
Vardiman J; Reichard K
Am J Clin Pathol; 2015 Jul; 144(1):29-43. PubMed ID: 26071460
[TBL] [Abstract][Full Text] [Related]
23. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
24. Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia.
Chen X; Othus M; Wood BL; Walter RB; Becker PS; Percival ME; Abkowitz JL; Appelbaum FR; Estey EH
Leuk Lymphoma; 2021 May; 62(5):1226-1233. PubMed ID: 33345655
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC).
Arber DA; Erba HP
Am J Clin Pathol; 2020 Nov; 154(6):731-741. PubMed ID: 32864703
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.
Ikegawa S; Doki N; Kurosawa S; Yamaguchi T; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Leuk Lymphoma; 2016; 57(1):76-80. PubMed ID: 26084204
[TBL] [Abstract][Full Text] [Related]
27. Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal.
Estey E; Hasserjian RP; Döhner H
Blood; 2022 Jan; 139(3):323-332. PubMed ID: 34111285
[TBL] [Abstract][Full Text] [Related]
28. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
29. The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications.
Park HS; Kim HK; Kim HS; Yang Y; Han HS; Lee KH; Son BR; Kwon J
Ann Hematol; 2022 Dec; 101(12):2645-2654. PubMed ID: 36220882
[TBL] [Abstract][Full Text] [Related]
30. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
[TBL] [Abstract][Full Text] [Related]
31. Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report.
Sheng XF; Hong LL; Huang FY; Zhuang HF
J Int Med Res; 2022 Sep; 50(9):3000605221122741. PubMed ID: 36134564
[TBL] [Abstract][Full Text] [Related]
32. Interrogation of molecular profiles can help in differentiating between MDS and AML with MDS-related changes.
Badar T; Szabo A; Sallman D; Komrojki R; Lancet J; Padron E; Song J; Hussaini MO
Leuk Lymphoma; 2020 Jun; 61(6):1418-1427. PubMed ID: 32013644
[TBL] [Abstract][Full Text] [Related]
33. Detection of the KIT
Craig JW; Hasserjian RP; Kim AS; Aster JC; Pinkus GS; Hornick JL; Steensma DP; Coleman Lindsley R; DeAngelo DJ; Morgan EA
Mod Pathol; 2020 Jun; 33(6):1135-1145. PubMed ID: 31896808
[TBL] [Abstract][Full Text] [Related]
34. Genetic Factors in Acute Myeloid Leukemia With Myelodysplasia-Related Changes.
Fang H; He R; Chiu A; Viswanatha DS; Ketterling RP; Patnaik MS; Reichard KK
Am J Clin Pathol; 2020 Apr; 153(5):656-663. PubMed ID: 31977035
[TBL] [Abstract][Full Text] [Related]
35. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
Chanswangphuwana C; Polprasert C; Owattanapanich W; Kungwankiattichai S; Tantiworawit A; Rattanathammethee T; Limvorapitak W; Saengboon S; Niparuck P; Puavilai T; Julamanee J; Saelue P; Wanitpongpun C; Nakhakes C; Prayongratana K; Sriswasdi C
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1075-e1083. PubMed ID: 36117042
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
Gonçalves AC; Alves R; Baldeiras I; Cortesão E; Carda JP; Branco CC; Oliveiros B; Loureiro L; Pereira A; Nascimento Costa JM; Sarmento-Ribeiro AB; Mota-Vieira L
Mol Carcinog; 2017 Jan; 56(1):130-148. PubMed ID: 26950655
[TBL] [Abstract][Full Text] [Related]
37. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
[TBL] [Abstract][Full Text] [Related]
38. RUNX1 mutations in MDS, s-AML, and de novo AML: differences in accompanying genetic alterations and outcome.
Stengel A; Kern W; Meggendorfer M; Haferlach T; Haferlach C
Leuk Lymphoma; 2019 May; 60(5):1334-1336. PubMed ID: 30997874
[No Abstract] [Full Text] [Related]
39. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
[TBL] [Abstract][Full Text] [Related]
40. Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms.
Seethy AA; Pethusamy K; Kushwaha T; Kumar G; Talukdar J; Chaubey R; Sundaram UD; Mahapatra M; Saxena R; Dhar R; Inampudi KK; Karmakar S
BMC Cancer; 2023 Oct; 23(1):1035. PubMed ID: 37884893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]